Beryl Capital Management
Beryl Capital Management reported 7 stocks worth $111M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are Janus Henderson Group PLC (66.4%), Esperion Therapeutics Inc NE (12.7%) and Apogee Therapeutics Inc (7.0%). Compared with Q1 2026, the fund opened new positions in SNX and sold out of GLDD, STKL and ADEA.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | JANUS HENDERSON GROUP PLC | $73.5M | 66.4% | 1.4M | New position | 1 of 8 | |
| 2 | ESPERION THERAPEUTICS INC NE | $14M | 12.7% | 4.4M | New position | 1 of 8 | |
| 3 | APOGEE THERAPEUTICS INC | $7.8M | 7.0% | 59K | New position | 1 of 8 | |
| 4 | SILA REALTY TRUST INC | $6.1M | 5.5% | 200K | New position | 1 of 8 | |
| 5 | AVANOS MED INC | $3.9M | 3.5% | 155K | New position | 1 of 8 | |
| 6 | TAYLOR MORRISON HOME CORP | $3.6M | 3.2% | 50K | New position | 1 of 8 | |
| 7 |  SNX TD Synnex Corporation | $1.8M | 1.7% | 6,853 | New position | 1 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
MASIMO CORP | $38.6M | 217K |
TERNS PHARMACEUTICALS INC | $25.2M | 479K |
 GLDD GREAT LAKES DREDGE & DOCK CO | $15.5M | 913K |
DAY ONE BIOPHARMACEUTICALS I | $11M | 514K |
 STKL Sunopta Inc | $9.8M | 1.5M |
🔒 Free account: see all 8.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Beryl Capital Management 13F FAQ
What does Beryl Capital Management own?
Beryl Capital Management reported 7 stocks worth $111M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are Janus Henderson Group PLC (66.4%), Esperion Therapeutics Inc NE (12.7%) and Apogee Therapeutics Inc (7.0%). The table above lists every position in the filing (the top 10 without an account).
What did Beryl Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 7 new positions, 0 added to, 0 trimmed and 8 sold out. New positions include SNX. It sold all of GLDD, STKL and ADEA.
When will Beryl Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Beryl Capital Management's portfolio worth?
The Q2 2026 filing reports $111M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.